Investigation of the reasons for withdrawal from long-term treatment with mirabegron of treatment-naive Japanese female patients with overactive bladder in the real-world clinical setting

Investigation of the reasons for withdrawal from long-term treatment with mirabegron of treatment-naive Japanese female patients with overactive bladder in the real-world clinical setting - Reasons for withdrawal from mirabegron for OAB

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029048

Enrollment

Registered

2017-09-09

Start date

2011-10-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Post-menopausal treatment-naive Japanese female patients who visited the hospital for the symptoms of OAB and were clinically diagnosed with OAB

Exclusion criteria

Exclusion criteria: Patients with premenopausal, urinary tract infection, large postvoid residual volume (more than 150 mL), a previous treatment history for OAB, and contraindications to use of mirabegron

Design outcomes

Primary

Measure	Time frame
The reasons for withdrawal from the treatment with mirabegron of treatment-naive Japanese female patients with overactive bladder	—

Countries

Japan

Contacts

Public ContactYoshinori Tanaka

Hokkaido Prefectural Esashi Hospital Division of Urology

rinoshiyokanata@me.com0139-52-0036

Outcome results